Goldman Sachs lowered the firm’s price target on Calumet (CLMT) to $17 from $21 but keeps a Buy rating on the shares. The firm is updating ...

Intel (INTC) has had a rough few years, but its board isn’t backing down from its turnaround efforts. With former CEO Pat Gelsinger stepping ...